Skip to main content

Eosinophilic Duodenitis (EoD) clinical trials at UCSF

1 research study open to eligible people

Eosinophilic duodenitis (EoD) is a condition where certain white blood cells cause inflammation in the intestines. UCSF is researching how Dupilumab helps adults and teens with eosinophilic gastritis and duodenitis. The study also checks for any side effects.

Showing trials for

Last updated: